AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Knoops, S Groeneveld, ABJ Kamp, O Lagrand, WK Hoekman, K
Citation: S. Knoops et al., Granulocyte-macrophage colony-stimulating factor (GM-CSF) decreases left ventricular function. An echocardiographic study in cancer patients, CYTOKINE, 14(3), 2001, pp. 184-187

Authors: Van den Brande, J Panday, VRN Hoekman, K Rosing, H Huijskes, RVHP Verheijen, RHM Beijnen, JH Vermorken, JB
Citation: J. Van Den Brande et al., Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors, AM J CL ONC, 24(4), 2001, pp. 401-403

Authors: van Triest, B Pinedo, HM Blaauwgeers, JLG van Diest, PJ Schoenmakers, PS Voorn, DA Smid, K Hoekman, K Hoitsma, HFW Peters, GJ
Citation: B. Van Triest et al., Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer, CLIN CANC R, 6(3), 2000, pp. 1063-1072

Authors: Verheul, HMW Hoekman, K Lupu, F Broxterman, HJ van der Valk, P Kakkar, AK Pinedo, HM
Citation: Hmw. Verheul et al., Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas, CLIN CANC R, 6(1), 2000, pp. 166-171

Authors: van Herpen, CML Jansen, RLH Kruit, WHJ Hoekman, K Groenewegen, G Osanto, S De Mulder, PHM
Citation: Cml. Van Herpen et al., Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracilfor progressive metastatic renal cell carcinoma: a multicenter phase II study, BR J CANC, 82(4), 2000, pp. 772-776

Authors: Verheul, HMW Jorna, AS Hoekman, K Broxterman, HJ Gebbink, MFBG Pinedo, HM
Citation: Hmw. Verheul et al., Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets, BLOOD, 96(13), 2000, pp. 4216-4221

Authors: Broxterman, HJ Hoekman, K
Citation: Hj. Broxterman et K. Hoekman, Direct activation of caspases by RGD-peptides may increase drug sensitivity of tumour cells, DRUG RESIST, 2(3), 1999, pp. 139-141

Authors: Lankelma, J Dekker, H Luque, RF Luykx, S Hoekman, K van der Valk, P van Diest, PJ Pinedo, HM
Citation: J. Lankelma et al., Doxorubicin gradients in human breast cancer, CLIN CANC R, 5(7), 1999, pp. 1703-1707

Authors: Hoekman, K van Doorn, J Gloudemans, T Maassen, JA Schuller, AGP Pinedo, HM
Citation: K. Hoekman et al., Hypoglycaemia associated with the production of insulin-like growth factorII and insulin-like growth factor binding protein 6 by a haemangiopericytoma, CLIN ENDOCR, 51(2), 1999, pp. 247-253

Authors: Postma, TJ Hoekman, K van Riel, JMGH Heimans, JJ Vermorken, JB
Citation: Tj. Postma et al., Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatinin patients with advanced ovarian cancer, J NEURO-ONC, 45(3), 1999, pp. 241-246

Authors: Prinssen, HM Hoekman, K Burger, CW
Citation: Hm. Prinssen et al., Clostridium septicum myonecrosis and ovarian cancer: A case report and review of literature, GYNECOL ONC, 72(1), 1999, pp. 116-119

Authors: Hoekman, K McCormick, J Gross, MUM
Citation: K. Hoekman et al., The optimal context for gifted students: A preliminary exploration of motivational and affective considerations, GIFT CHILD, 43(3), 1999, pp. 170-193

Authors: Hoekman, K van der Vijgh, WJF Vermorken, JB
Citation: K. Hoekman et al., Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer, DRUGS, 57(2), 1999, pp. 133-155
Risultati: 1-13 |